South Korean biotech companies are working to diversify from China in anticipation that the US could tighten export restrictions on the sector to bolster its domestic industry and curb Chinese growth.
The Biden administration has identified biotechnology and biomanufacturing as strategic industries and is expected to introduce more specific measures within months.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased